Alpha 2.0
Login Register
» Articles » PMID: 30567227

Olmesartan-associated Severe Gastritis and Enteropathy

Overview
Journal BMJ Case Rep
Specialty General Medicine
Date 2018 Dec 21
PMID 30567227
Citations 5
Authors
Lavanya Shenbagaraj
Gillian Swift
Affiliations
Soon will be listed here.
Abstract

Olmesartan is an angiotensin II receptor antagonist, used in the treatment of hypertension. We report a case of olmesartan-associated severe gastritis with enteropathy in a 74-year-old woman who presented with mainly upper gastrointestinal symptoms. There was significant endoscopic improvement in the mucosal inflammation on stopping the drug. Subsequent gastroscopy showed mucosal healing and normal gastric and duodenal mucosa. To our knowledge, this is the first case report of olmesartan-associated gastritis and enteropathy predominantly involving and affecting the whole of stomach with limited small bowel involvement.

Citing Articles

Olmesartan-Induced Enteropathy: A Rare Case of Chronic Diarrhea.

Gurgel S, Medeiros K, Lima de Paiva S, Gurgel Filho J Case Rep Med. 2024; 2024:2666671.

PMID: 39735218 PMC: 11671654. DOI: 10.1155/carm/2666671.

Drug-induced mucosal alterations observed during esophagogastroduodenoscopy.

Iwamuro M, Kawano S, Otsuka M World J Gastroenterol. 2024; 30(16):2220-2232.

PMID: 38690017 PMC: 11056913. DOI: 10.3748/wjg.v30.i16.2220.

The histological spectrum of ARB-induced gastritis.

Storozuk T, Brown I, Lagana S, Westerhoff M, Setia N, Hart J Histopathology. 2022; 81(5):653-660.

PMID: 35945664 PMC: 9804261. DOI: 10.1111/his.14766.

Olmesartan-Induced Enteropathy: A Report of an Unusual Cause of Chronic Diarrhea.

Sotiropoulos C, Sakka E, Diamantopoulou G, Theocharis G, Thomopoulos K Cureus. 2021; 13(8):e17004.

PMID: 34540405 PMC: 8423377. DOI: 10.7759/cureus.17004.

Autoimmune Gastritis Treated With Mycophenolate Mofetil.

Harb A, Vemulapalli R, Gopal P, Park J ACG Case Rep J. 2020; 7(12):e00496.

PMID: 33324715 PMC: 7725257. DOI: 10.14309/crj.0000000000000496.

References
1.
Dreifuss S, Tomizawa Y, Farber N, Davison J, Sohnen A . Spruelike enteropathy associated with olmesartan: an unusual case of severe diarrhea. Case Rep Gastrointest Med. 2013; 2013:618071. PMC: 3610358. DOI: 10.1155/2013/618071. View
2.
Fiorucci G, Puxeddu E, Colella R, Paolo Reboldi G, Villanacci V, Bassotti G . Severe spruelike enteropathy due to olmesartan. Rev Esp Enferm Dig. 2014; 106(2):142-4. DOI: 10.4321/s1130-01082014000200011. View
3.
Herman M, Rubio-Tapia A, Wu T, Murray J . A Case of Severe Sprue-Like Enteropathy Associated With Valsartan. ACG Case Rep J. 2015; 2(2):92-4. PMC: 4435362. DOI: 10.14309/crj.2015.15. View
4.
Marthey L, Cadiot G, Seksik P, Pouderoux P, Lacroute J, Skinazi F . Olmesartan-associated enteropathy: results of a national survey. Aliment Pharmacol Ther. 2014; 40(9):1103-9. DOI: 10.1111/apt.12937. View
5.
Rubio-Tapia A, Herman M, Ludvigsson J, Kelly D, Mangan T, Wu T . Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc. 2012; 87(8):732-8. PMC: 3538487. DOI: 10.1016/j.mayocp.2012.06.003. View